Probing the Interactions of Lamotrigine and Phenobarbital with Tau Protein: Experimental and Molecular Modeling Studies

AuthorAmirreza Gholamien
AuthorGholamreza Dehghanen
AuthorSamaneh Rashtbarien
AuthorAbolghasem Jouybanen
Issued Date2022-12-31en
AbstractTau, as a small protein in neurons, plays a main role in stabilizing and assembling the internal microtubules. Here, the effects of antiepileptic drugs, including lamotrigine (LTG) and phenobarbital (PHB), on tau protein structure have been investigated by surface plasmon resonance (SPR), fluorescence spectroscopy along molecular modeling. Fluorescence data analysis revealed that both drugs quench the intrinsic emission intensity of tau protein via a static quenching mechanism. Analysis of SPR data at three different temperatures revealed that binding of LTG and PHB to tau protein leads to a decrease and increase in equilibrium constants (KD) values with increasing temperature, respectively. Therefore, the affinity of LTG decreases and PHB increases with increasing temperature. In addition, molecular docking studies indicated that both LTG and PHB bind to the S1 pocket of tau protein. Our data demonstrated the preventive effect of two important antiepileptic pharmaceuticals on the aggregation of tau protein. Given that any damage to the tau protein possibly leads to neurodegenerative diseases, this study can provide useful and important information and a basis for further research and study to treat tauopathy.en
DOIhttps://doi.org/10.5812/ijpr-129599en
KeywordAntiepileptic Drugsen
KeywordLamotrigineen
KeywordPhenobarbitalen
KeywordTau Proteinen
KeywordMolecular Dockingen
KeywordSurface Plasmon Resonanceen
PublisherBrieflandsen
TitleProbing the Interactions of Lamotrigine and Phenobarbital with Tau Protein: Experimental and Molecular Modeling Studiesen
TypeResearch Articleen

Files